AI_BinomLabs

AI-platform for Accelerate discovery by simulation biochemical in vitro experiments.
The aim of the AI platform is to replace verification and intermediate
in vitro experiments by predicting experimental data.
https://binomlabs.com/
Pharma and biotech spend tens of billions each year on in‑vitro work, where variability and low first‑try success increse cost and timelines.  BinomLabs applies AI/ML to deliver experiment prognoses that align with lab data up to R = 0.93, demonstrated on real in‑vitro studies.

With this guidance, teams typically reduce ~10 experiments to 3–4, lifting the proportion of successful first attempts and freeing capital for the highest‑value questions. We enhance expert judgment—turning every scientist into a faster, more precise decision‑maker